Aspirin use does not improve outcomes for cancer patients, but may lower breast tissue density, allowing for earlier detection

Whether aspirin may help prevent or reduce the risk of breast cancer remains a hotly debated research question. While past studies have indicated a potential benefit, most recently in hormone receptor-positive breast cancers, one new study suggests otherwise. Aspirin does not appear to be protective or associated with improved clinical outcomes or survival among breast cancer patients with aggressive disease, the researchers of one study report. However, another study suggests aspirin may in fac...